We are live on
!
Find out more
WCM
Weld Capital Management Portfolio holdings
AUM
$98.8M
1-Year Est. Return
52.83%
This Fund
S&P 500
This Quarter
Est. Return
+31.95%
1 Year Est. Return
+52.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
+$58.8M
(+30%)
Cap. Flow
+$27.3M
Cap. Flow
% of AUM
10.69%
Top 10 Holdings %
Top 10 Hldgs %
8.39%
Holding
719
New
321
Increased
57
Reduced
70
Closed
271
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.86M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$2.35M |
| 3 |
Voya Financial
VOYA
|
+$2.1M |
| 4 |
Idacorp
IDA
|
+$2.03M |
| 5 |
Cardinal Health
CAH
|
+$1.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$2.11M |
| 2 |
VER
VEREIT, Inc.
VER
|
+$1.99M |
| 3 |
Lam Research
LRCX
|
+$1.92M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.84M |
| 5 |
Vornado Realty Trust
VNO
|
+$1.72M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.35% |
| 2 | Consumer Discretionary | 15.99% |
| 3 | Technology | 12.47% |
| 4 | Financials | 12.13% |
| 5 | Industrials | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sally Beauty Holdings
SBH
$1.48B
| $1.53M | 0.6% |
+122,258
| New | +$1.34M |
|
27
Chemours
CC
$2.57B
| $1.53M | 0.6% |
99,607
+25,037
| +34% | +$317K |
|
28
Cboe Global Markets
CBOE
$31.1B
| $1.51M | 0.59% |
16,199
+8,006
| +98% | +$789K |
|
|
CMA
29
DELISTED
Comerica
CMA
| $1.47M | 0.58% |
+38,641
| New | +$1.35M |
|
|
SAFM
30
DELISTED
Sanderson Farms Inc
SAFM
| $1.47M | 0.58% |
+12,697
| New | +$1.63M |
|
31
Peloton Interactive
PTON
$2.84B
| $1.46M | 0.57% |
+25,231
| New | +$1.04M |
|
32
Honeywell
HON
$78.3B
| $1.46M | 0.57% |
10,694
+7,400
| +225% | +$979K |
|
33
Baidu
BIDU
$35.6B
| $1.44M | 0.56% |
+11,982
| New | +$1.28M |
|
34
Broadcom
AVGO
$1.81T
| $1.42M | 0.56% |
+45,020
| New | +$1.26M |
|
35
Humana
HUM
$46.7B
| $1.41M | 0.55% |
+3,632
| New | +$1.36M |
|
36
Markel Group
MKL
$25.5B
| $1.37M | 0.54% |
+1,487
| New | +$1.35M |
|
37
NNN REIT
NNN
$9.37B
| $1.36M | 0.53% |
38,420
+22,070
| +135% | +$722K |
|
38
Prosperity Bancshares
PB
$8.82B
| $1.36M | 0.53% |
22,871
+10,828
| +90% | +$625K |
|
39
AutoZone
AZO
$50.9B
| $1.36M | 0.53% |
1,202
+294
| +32% | +$310K |
|
40
Molson Coors Class B
TAP
$7.97B
| $1.35M | 0.53% |
39,344
-8,491
| -18% | -$339K |
|
41
Coca-Cola
KO
$380B
| $1.28M | 0.5% |
+28,695
| New | +$1.32M |
|
|
WPX
42
DELISTED
WPX Energy, Inc.
WPX
| $1.27M | 0.5% |
+199,590
| New | +$1.13M |
|
|
TWOU
43
DELISTED
2U Inc
TWOU
| $1.27M | 0.5% |
+1,112
| New | +$993K |
|
44
Parker-Hannifin
PH
$125B
| $1.25M | 0.49% |
+6,834
| New | +$1.1M |
|
45
Boeing
BA
$175B
| $1.24M | 0.49% |
+6,787
| New | +$1.04M |
|
46
UDR
UDR
$12.7B
| $1.24M | 0.49% |
+33,269
| New | +$1.24M |
|
47
Ironwood Pharmaceuticals
IRWD
$626M
| $1.24M | 0.49% |
120,344
+38,394
| +47% | +$393K |
|
48
Avnet
AVT
$7.07B
| $1.24M | 0.48% |
44,295
+12,927
| +41% | +$359K |
|
49
KB Home
KBH
$3.54B
| $1.23M | 0.48% |
+39,954
| New | +$1.1M |
|
50
Nektar Therapeutics
NKTR
$2.39B
| $1.2M | 0.47% |
+3,445
| New | +$1.07M |
|
Similar funds
BCM
CCM
RGM
RC
TCM
AC
QVT
WFWM
Weld Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Weld Capital Management held 719 positions worth $255M, up 30% from $196M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Weld Capital Management deployed $27.3M of net new capital in Q2 2020, opening 321 new positions and adding to 57 existing holdings. Its largest new stake was Bristol-Myers Squibb: 47,881 shares worth $2.81M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Lam Research, an estimated $1.92M trimmed.
- Weld Capital Management's largest Q2 2020 buy was Bristol-Myers Squibb: 47,881 shares worth $2.81M.
- Weld Capital Management added most to GoDaddy in Q2 2020, an estimated $1.61M increase.
- Weld Capital Management's biggest Q2 2020 reduction was Lam Research, cutting an estimated $1.92M.
- Weld Capital Management fully exited Vertex Pharmaceuticals in Q2 2020, selling an estimated $2.11M.
- Weld Capital Management's ten largest holdings make up 8.4% of its $255M portfolio in Q2 2020.
- Weld Capital Management opened 321 new positions and closed 271 in Q2 2020.
- Weld Capital Management's portfolio value rose 30% quarter-over-quarter to $255M.
Based on Weld Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.